Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide

por Irvine, A.D., Mina‐Osorio, P.
Publicado 2019

Report on the fifth international workshop on the CCN family of genes

por Irvine, A. E., Perbal, B., Yeger, H.
Publicado 2009

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

por Jodrell, D. I., Irvine, A. T., McCready, V. R., Woodcraft, E., Smith, I. E.
Publicado 1988

Web-based Intervention to Promote Physical Activity by Sedentary Older Adults: Randomized Controlled Trial

por Irvine, A. Blair, Gelatt, Vicky A, Seeley, John R, Macfarlane, Pamela, Gau, Jeff M
Publicado 2013

Mental health related differences in healthcare worker’s temporal patterns of cognition, stress, mood, and sleep during the COVID-19 pandemic

por Anwyl-Irvine, A., Allen, L.A., Cormack, F., Searle, A., Taptiklis, N., Kaula, A., Cashdollar, N.
Publicado 2022

Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis

por McAleer, M. A., Jakasa, I., Stefanovic, N., McLean, W. H. I., Kezic, S., Irvine, A. D.
Publicado 2021

Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models

por Crawford, L J, Chan, E T, Aujay, M, Holyoake, T L, Melo, J V, Jorgensen, H G, Suresh, S, Walker, B, Irvine, A E
Publicado 2014

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement

por Leshem, Y.A., Bissonnette, R., Paul, C., Silverberg, J.I., Irvine, A.D., Paller, A.S., Cork, M.J., Guttman‐Yassky, E.
Publicado 2019

Nottingham Eczema Severity Scoring tool can identify children at high risk of food allergy to cow’s milk, egg and peanut

por Oosthuizen, Lizalet, Mc Aleer, M A, Watson, R M, O’Regan, G M, Byrne, A, Crispino-O’Connell, G, Irvine, A D
Publicado 2015

Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis

por McAleer, M.A., Jakasa, I., Hurault, G., Sarvari, P., McLean, W.H.I., Tanaka, R.J., Kezic, S., Irvine, A.D.
Publicado 2018

Mobile-Web App to Self-Manage Low Back Pain: Randomized Controlled Trial

por Irvine, A Blair, Russell, Holly, Manocchia, Michael, Mino, David E, Cox Glassen, Terri, Morgan, Rebecca, Gau, Jeff M, Birney, Amelia J, Ary, Dennis V
Publicado 2015

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐...

por Vermeulen, F.M., Gerbens, L.A.A., Schmitt, J., Deleuran, M., Irvine, A.D., Logan, K., Ouwerkerk, W., Vestergaard, C., Flohr, C., Spuls, P.I.
Publicado 2020

Mutations in desmoglein 1 cause diverse inherited palmoplantar keratoderma phenotypes: implications for genetic screening

por Lovgren, M.‐L., McAleer, M.A., Irvine, A.D., Wilson, N.J., Tavadia, S., Schwartz, M.E., Cole, C., Sandilands, A., Smith, F.J.D., Zamiri, M.
Publicado 2017

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity

por Kezic, S, O’Regan, G M, Yau, N, Sandilands, A, Chen, H, Campbell, L E, Kroboth, K, Watson, R, Rowland, M, Irwin McLean, W H, Irvine, A D
Publicado 2011

Inertial displacement of a domain wall excited by ultra-short circularly polarized laser pulses

por Janda, T., Roy, P. E., Otxoa, R. M., Šobáň, Z., Ramsay, A., Irvine, A. C., Trojanek, F., Surýnek, M., Campion, R. P., Gallagher, B. L., Němec, P., Jungwirth, T., Wunderlich, J.
Publicado 2017

Early‐life regional and temporal variation in filaggrin‐derived natural moisturizing factor, filaggrin‐processing enzyme activity, corneocyte phenotypes and plasmin activity: impli...

por McAleer, M.A., Jakasa, I., Raj, N., O'Donnell, C.P.F., Lane, M.E., Rawlings, A.V., Voegeli, R., McLean, W.H.I., Kezic, S., Irvine, A.D.
Publicado 2018

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

por Drucker, A.M., Eyerich, K., de Bruin‐Weller, M.S., Thyssen, J.P., Spuls, P.I., Irvine, A.D., Girolomoni, G., Dhar, S., Flohr, C., Murrell, D.F., Paller, A.S., Guttman‐Yassky, E.
Publicado 2018

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

por Alexander, H., Paller, A.S., Traidl‐Hoffmann, C., Beck, L.A., De Benedetto, A., Dhar, S., Girolomoni, G., Irvine, A.D., Spuls, P., Su, J., Thyssen, J.P., Vestergaard, C., Werfel, T., Wollenberg, A., Deleuran, M., Flohr, C.
Publicado 2019

The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from patients with atopic dermatitis

por Harkins, C.P., McAleer, M.A., Bennett, D., McHugh, M., Fleury, O.M., Pettigrew, K.A., Oravcová, K., Parkhill, J., Proby, C.M., Dawe, R.S., Geoghegan, J.A., Irvine, A.D., Holden, M.T.G.
Publicado 2018

What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review

por Blakeway, H., Van‐de-Velde, V., Allen, V.B., Kravvas, G., Palla, L., Page, M.J., Flohr, C., Weller, R.B., Irvine, A.D., McPherson, T., Roberts, A., Williams, H.C., Reynolds, N., Brown, S.J., Paternoster, L., Langan, S.M.
Publicado 2020